Danking Pharmaceuticals
Seed Round in 2025
Danatlas is a pharmaceutical company that develops drugs designed for oncology treatment. It also provides drug research and development in the fields of cancer, inflammation, blood, and metabolic diseases.
Bioyond Tech
Series A in 2024
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Terapark is a technology company focused on developing terahertz chip solutions, primarily through integrated circuit modules and related equipment. It specializes in CMOS terahertz integrated circuits and real-time imaging systems, as well as terahertz sensors. By leveraging standard silicon technology, such as CMOS and SiGe, with nanometer precision, Terapark aims to make terahertz technology more accessible and cost-effective. The company's innovations promote the application of terahertz technology across various domains, including intelligent manufacturing inspections, transportation monitoring, energy sector oversight, environmental assessments, and health monitoring. Through its advancements, Terapark seeks to drive the wider adoption of terahertz solutions in multiple industries.
Zhixin Haozheng
Seed Round in 2024
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes.
Caprico Biotechnologies
Seed Round in 2024
Caprico Biotechnologies is a biotechnology company focused on developing and providing flow cytometry reagents and services for various applications, including basic and clinical research and diagnostics. The company specializes in immunophenotyping products, offering a range of ASR reagents tailored for T-cell clonality and non-human primate primary antibodies. Additionally, Caprico provides custom assay design and development services, as well as the production and conjugation of antibodies specifically for flow cytometry applications. Through its innovative solutions, Caprico Biotechnologies aims to enhance the operational efficiency of researchers in the field.
Fibresound Technology
Seed Round in 2023
Fibresound Technology is a chip development company that specializes in the R&D and design of piezoelectric MEMS microphone chips.
Shitong Microelectronics
Seed Round in 2023
Shitong Microelectronics specializes in the design and development of machine vision-detecting sensors, particularly 3D sensors. It seeks to create 3D sensors with high precision, low power consumption, and competitive prices.
LeadBio Tech
Series A in 2023
LeadBio Tech is a biotechnology company focused on developing bioartificial blood vessel medical devices. It specializes in tissue engineering and regeneration solutions to replace and repair human tissues and organs. The company's flagship product is degradable bioartificial blood vessels based on skeleton immune wrapping technology, designed for use in arteriovenous grafts (AVG) surgeries. These advanced artificial vessels aim to improve patient outcomes by providing superior alternatives to traditional vascular access methods.
O-Cubes focus on micro chip research and development in wireless communication field.
dina dollar liter
Seed Round in 2023
dina dollar litre is a nucleic acid nanocarrier technology provider who focuses on the development of nucleic acid nanocarrier technology.
Levinthal
Angel Round in 2023
Levinthal is a company specializing in AI-driven protein design, focusing on enhancing industrial production of biological molecules and microbes. Their platform offers services that leverage artificial intelligence for applications in food safety, medical care, synthetic biology, feed, cosmetics, and environmental protection. The company develops advanced algorithms and experimental technologies to enable enterprises to design more stable and efficient enzymes, thereby improving various industrial processes.
Easy Logic
Series A in 2023
Easy Logic is a developer of electronic design automation tools.
Jinfang Pharmaceutical
Series C in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
Tingke Biotechnology
Series A in 2023
Tingke Biotechnology develops microfluidic products for industry partners. They offer products that include vitro diagnostics, organ chips, nanomedicine, material synthesis, food safety, and environmental protection testing.
Zhishan Weixin Biotechnology
Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Ruiyun Cold Chain
Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Terapark
Seed Round in 2022
Terapark is a technology company focused on developing terahertz chip solutions, primarily through integrated circuit modules and related equipment. It specializes in CMOS terahertz integrated circuits and real-time imaging systems, as well as terahertz sensors. By leveraging standard silicon technology, such as CMOS and SiGe, with nanometer precision, Terapark aims to make terahertz technology more accessible and cost-effective. The company's innovations promote the application of terahertz technology across various domains, including intelligent manufacturing inspections, transportation monitoring, energy sector oversight, environmental assessments, and health monitoring. Through its advancements, Terapark seeks to drive the wider adoption of terahertz solutions in multiple industries.
Ribo Biotech
Series E in 2022
Ribo Biotech develops RNA interference drugs and is committed to the research and development of small nucleic acid drugs.
Terapark
Seed Round in 2022
Terapark is a technology company focused on developing terahertz chip solutions, primarily through integrated circuit modules and related equipment. It specializes in CMOS terahertz integrated circuits and real-time imaging systems, as well as terahertz sensors. By leveraging standard silicon technology, such as CMOS and SiGe, with nanometer precision, Terapark aims to make terahertz technology more accessible and cost-effective. The company's innovations promote the application of terahertz technology across various domains, including intelligent manufacturing inspections, transportation monitoring, energy sector oversight, environmental assessments, and health monitoring. Through its advancements, Terapark seeks to drive the wider adoption of terahertz solutions in multiple industries.
NuProbe, Inc. is a genomics and molecular diagnostics company that specializes in noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative polymerase chain reaction (qPCR) mutation detection. The company's innovative probe technology facilitates a Sample-In Answer-Out (SIAO) solution, integrating cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretations. This precision diagnostic technology is designed for the early detection of cancer and infectious diseases, offering high sensitivity and the ability to capture disease signatures comprehensively. As a result, healthcare specialists are empowered to act swiftly, enabling timely treatment for patients.
Yueer Gene
Series B in 2022
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.
PPIO is a decentralized cloud computing project founded in 2018 by Bill Yao and Wayne Wang, aimed at creating a distributed cloud service platform that harnesses global computing resources for widespread use. The company focuses on edge cloud computing, utilizing big data and distributed computing technology to offer low-latency, high-bandwidth services. PPIO operates extensive micro data centers and computing resources across over 1,000 cities and regions in China, addressing the needs of various sectors, including audio and video internet firms and cloud computing companies. Its offerings include eBareMetal, eContainer, and a range of edge computing services such as content delivery networks (CDN), live streaming, transcoding, application performance monitoring, and AI computing. By integrating these services, PPIO aims to facilitate efficient data distribution and processing for developers who prioritize speed, affordability, and privacy.
GenFleet Therapeutics
Series C in 2021
GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.
Xiaoxiang Zhihe
Series A in 2021
Xiaoxiang Zhihe is a packaging innovation Internet service platform from design to production. Xiaoxiang Zhihe focuses on professional packaging innovation, providing brands with product strategy, packaging creative design and structure development, brand color consistency management, sample production, packaging and printing production management and other services. Xiaoxiang Zhihe is committed to recreating an industrial Internet platform in China’s printing and packaging industry to centralize and online decentralized production capacity. At present, the company’s self-developed packaging and printing supply chain management platform connects more than 40 excellent design institutions and The 200 member factories provide a more convenient design innovation, flexible manufacturing, high-efficiency and high-quality intelligent supply chain service platform for the packaging upgrade of Chinese brands.
PPIO is a decentralized cloud computing project founded in 2018 by Bill Yao and Wayne Wang, aimed at creating a distributed cloud service platform that harnesses global computing resources for widespread use. The company focuses on edge cloud computing, utilizing big data and distributed computing technology to offer low-latency, high-bandwidth services. PPIO operates extensive micro data centers and computing resources across over 1,000 cities and regions in China, addressing the needs of various sectors, including audio and video internet firms and cloud computing companies. Its offerings include eBareMetal, eContainer, and a range of edge computing services such as content delivery networks (CDN), live streaming, transcoding, application performance monitoring, and AI computing. By integrating these services, PPIO aims to facilitate efficient data distribution and processing for developers who prioritize speed, affordability, and privacy.
KingstronBio
Series C in 2021
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.
Chuantu Microelectronics
Series B in 2021
Chuantu Microelectronics, established in 2016 and based in Shanghai, specializes in the design of chips. Its product portfolio includes radiofrequency analog chips, micromodules, and related solutions.
3N Tech is a manufacturer specializing in contact lens care products designed to enhance eye health. The company utilizes advanced biotechnology, specifically biomedical electrophoresis deproteinization technology, to create a range of solutions for contact lens users. Their product offerings include methods for protein precipitation removal, sterilization, antibacterial treatment, and safe storage of contact lenses. By focusing on these innovative technologies, 3N Tech aims to provide effective safety protection for contact lens users, ensuring that they can maintain healthy eyes while using their products.
Ruiyun Cold Chain
Angel Round in 2021
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Percipio.XYZ
Series B in 2021
Shanghai Percipio Information Technology Co., Ltd. is a technology company focused on 3D machine vision solutions. Founded in 2015 and headquartered in Shanghai, China, the company designs and manufactures 3D-depth cameras and offers corresponding software support. Its products are utilized across various sectors, including logistics, virtual reality, industrial control, and smart security. Percipio's advanced 3D vision technology enables clients to implement quality control through integrated hardware and algorithms that analyze product flows and generate actionable insights. The company's offerings are aimed at enhancing automation and efficiency in industries such as manufacturing, medical equipment, and automotive applications.
NuProbe, Inc. is a genomics and molecular diagnostics company that specializes in noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative polymerase chain reaction (qPCR) mutation detection. The company's innovative probe technology facilitates a Sample-In Answer-Out (SIAO) solution, integrating cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretations. This precision diagnostic technology is designed for the early detection of cancer and infectious diseases, offering high sensitivity and the ability to capture disease signatures comprehensively. As a result, healthcare specialists are empowered to act swiftly, enabling timely treatment for patients.
GenFleet Therapeutics
Venture Round in 2021
GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.
KingstronBio
Venture Round in 2020
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.
Virogin Biotech
Series C in 2020
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, specializes in the development of oncolytic virus therapeutics aimed at treating cancer. The company utilizes its innovative Synerlytic™ technical platform to enhance cancer treatment through novel immunotherapy approaches. Virogin's technology focuses on leveraging immunological principles to stimulate anticancer and antitumor immunity. By harnessing a robust and transient antiviral immune response, the company aims to improve systemic antitumor immunity via synergistic interactions with multiple therapeutic payloads. Virogin is dedicated to advancing its position as a leader in the field of immuno-oncology.
Bichen Pharmaceutical
Series A in 2020
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Jinfang Pharmaceutical
Series B in 2020
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
GenFleet Therapeutics
Series B in 2020
GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.
Yesmro, also known as Yimai Gongpin, is a retailer focused on providing small-business automation parts and industrial supplies. The company operates an e-commerce platform that caters to small- to medium-sized enterprises by offering a wide range of products, including electrical accessories, wires and cables, and industrial control components. Yesmro aims to make the procurement of industrial goods easier and more affordable for small businesses by leveraging technology and data-driven solutions. This commitment enables a broad spectrum of enterprises engaged in technological development to access essential industrial products conveniently and at a lower cost.
Percipio.XYZ
Series A in 2020
Shanghai Percipio Information Technology Co., Ltd. is a technology company focused on 3D machine vision solutions. Founded in 2015 and headquartered in Shanghai, China, the company designs and manufactures 3D-depth cameras and offers corresponding software support. Its products are utilized across various sectors, including logistics, virtual reality, industrial control, and smart security. Percipio's advanced 3D vision technology enables clients to implement quality control through integrated hardware and algorithms that analyze product flows and generate actionable insights. The company's offerings are aimed at enhancing automation and efficiency in industries such as manufacturing, medical equipment, and automotive applications.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.
Thorough Future
Seed Round in 2019
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.
Yesmro, also known as Yimai Gongpin, is a retailer focused on providing small-business automation parts and industrial supplies. The company operates an e-commerce platform that caters to small- to medium-sized enterprises by offering a wide range of products, including electrical accessories, wires and cables, and industrial control components. Yesmro aims to make the procurement of industrial goods easier and more affordable for small businesses by leveraging technology and data-driven solutions. This commitment enables a broad spectrum of enterprises engaged in technological development to access essential industrial products conveniently and at a lower cost.
Antekang Cheng
Seed Round in 2019
Antai Kangcheng is a research and development company specializing in tumor electric field treatment technology, particularly aimed at addressing glioblastoma multiforme. The company is dedicated to creating innovative treatment methods and equipment for tumor management and central nervous system injury rehabilitation. Antai Kangcheng has developed a precise treatment planning system that integrates biophysical models with multimodal imaging systems, allowing for personalized treatment solutions tailored to the needs of Chinese patients. Furthermore, the company has achieved the visualization of intracranial electric field strength and can effectively manage electro-nodes to track tumors, enabling patients to receive effective treatment at a lower cost.
Happy Cycle
Seed Round in 2019
Happy Cycle is a fitness studio brand based on the dynamic cycling category. Based on the concept of “Make Fitness Having a Better Life”, Happy Cycle offers immersive fitness scenes and dynamic cycling verticals with music, games, video, social and other entertainment elements, allowing users to complete their fitness in the entertainment experience.
Qinheli Biomedical
Seed Round in 2019
Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.
Chuantu Microelectronics
Series A in 2019
Chuantu Microelectronics, established in 2016 and based in Shanghai, specializes in the design of chips. Its product portfolio includes radiofrequency analog chips, micromodules, and related solutions.
LangRui Medical
Seed Round in 2019
LangRui Medical is a cardiac remote diagnosis service provider, which provides users with cardiac medical remote diagnosis, data analysis, data storage and other services, and uses its own network platform to move the ECG inspection project of the networked top three hospitals to the primary medical institutions. Hospital medical informatization level.
Apollomics
Series B in 2019
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.
Yesmro, also known as Yimai Gongpin, is a retailer focused on providing small-business automation parts and industrial supplies. The company operates an e-commerce platform that caters to small- to medium-sized enterprises by offering a wide range of products, including electrical accessories, wires and cables, and industrial control components. Yesmro aims to make the procurement of industrial goods easier and more affordable for small businesses by leveraging technology and data-driven solutions. This commitment enables a broad spectrum of enterprises engaged in technological development to access essential industrial products conveniently and at a lower cost.
Gongguizhijia
Series A in 2018
Gongguizhijia, established in 2014 and headquartered in Shanghai, China, is a commercial vehicle after-sales service platform. The company specializes in providing comprehensive technical support services for commercial vehicle maintenance stations and aftermarket customers. Their offerings include full vehicle repair, advanced calibration, data analysis, and various data management services to enhance the efficiency and accuracy of vehicle maintenance processes.
Iris Integrated Retail Information Solution
Series A in 2018
Iris Integrated Retail Information Solution is a provider of enterprise services focused on information technology for the retail sector. Based in Shanghai, China, the company offers a range of solutions, including IT retail data operations, business intelligence IT solutions, and cloud-based management systems. Iris specializes in the Iris BI 1.2 Pro series, an integrated application designed for various businesses involved in retail data processing. Additionally, the company develops mobile applications and offers services such as mobile IT product solutions, eBook production, and app development. Iris also provides IT consulting and training services, catering to the diverse needs of its clients in the retail industry.
AOSSCI is a developer of unmanned aerial vehicle (UAV) systems and control technologies designed for a range of industrial applications. The company specializes in high-performance all-electric drones, ground control stations, and flight simulation platforms that facilitate integrated flight control training. AOSSCI’s products are utilized in diverse sectors such as land surveying, public safety, power line inspection, resource exploration, and environmental protection. The company is committed to delivering innovative UAV solutions that enhance operational efficiency and safety across various industries, including oil exploration, landscape mapping, and smart urban management.
Chuantu Microelectronics
Seed Round in 2018
Chuantu Microelectronics, established in 2016 and based in Shanghai, specializes in the design of chips. Its product portfolio includes radiofrequency analog chips, micromodules, and related solutions.
XGimi
Corporate Round in 2018
XGimi is a developer and manufacturer of high-performance, multi-functional smart projectors and laser TVs, established in 2012 and based in Chengdu, China. The company specializes in high-definition projectors that are embedded with an Android operating system and offer three-dimensional viewing capabilities. XGimi is dedicated to creating affordable giant-screen projection solutions, aiming to enhance the viewing experience for consumers worldwide.
YCloset was an online clothing rental platform based in Beijing, founded in 2015. The company offered a subscription service that allowed users to rent women's clothing and accessories for a monthly fee, with no additional charges for individual items. Operating in approximately 40 cities across China, including major urban centers like Beijing, Shanghai, Guangzhou, and Shenzhen, YCloset partnered with over a hundred fashion brands to provide a diverse selection of apparel. The platform was accessible via mobile applications, enabling users to keep pace with the latest fashion trends without the need to purchase new garments. However, YCloset announced the closure of its operations by August 15, 2021.
Suzhou Ribo Life Science
Series B in 2017
Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.
Percans Oncology
Series B in 2017
Percans Oncology is a biotechnology company dedicated to advancing personalized cancer treatments. They specialize in developing individualized treatment plans by offering services such as cross-indication drug combination solutions, vitro susceptibility testing, and a tumor cell drug sensitivity detection kit. Their focus lies in creating innovative cancer-specific drug products centered around synthetic lethality and immunotherapy, aiming to enhance the effectiveness of each patient's treatment plan and extend lives.
Passiontec
Series A in 2016
Passiontec is a community e-commerce platform for life services. The company offers services including catering, food delivery, taxi-hailing, shared bicycles, hotel travel, movies, leisure activities, and entertainment, and it has apps that are well-known to customers like Meituan, Dianping, and Meituan Waimai. It is a social company that aims to develop a smart city and a better way of life by working closely with government and party agencies, academic institutions, the general public, public welfare organizations, and ecological partners.
Dream is a company that offers game creation services with the goal of creating a variety of web games, social games, and mobile Internet games. Clients can access a variety of online games cause of the company's gaming development services, which include numerous cross-platform gaming facilities that are also exported to other markets.